Located in Jena (Germany), SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening infections, one of the major causes of death in hospitals across the world. SIRS-Lab's vision is to support clinicians in their bedside decisions by providing them with fast and reliable high-performance point of care systems and thus, to improve therapeutic impact and reduce the mortality rate of patients.
aa sa is closely involved in the strategic and financial management of SIRS-Lab. In this context, aa sa delegates a member to the Board of Directors.
For more information about SIRS-Lab and its product offering, please visit www.SIRS-Lab.com.
related news
| 15 Jun 2010 | SIRS-Lab: SIRS-Lab and Analytik Jena cooperate on Sepsis Diagnostics |
| 10 Aug 2009 | SIRS-Lab: Barbara Staehelin elected as new CEO |
| 24 Apr 2009 | SIRS-Lab: pathogen identification - peer reviewed paper published |
| 04 Feb 2009 | SIRS-Lab appoints Ed Currie as Vice-President, Corporate Development |
| 11 Dec 2008 | SIRS-Lab appoints Anita Mitan as Executive VP Commercial to further accelerate the commercialisation of its unique sepsis diagnoistics suite |
| 08 Dec 2008 | SIRS-Lab receives CE approval for sepsis test "VYOO" and unfolds full clinical potential |
| 17 Oct 2008 | SIRS-Lab receives ISO certification for molecular in-vitro sepsis diagnostics |
| 22 Sep 2008 | SIRS-Lab and Dxs enter into licensing agreement for the applications of Scorpions Technology in Sepsis Test SIQNATURE |
| 29 Aug 2008 | SIRS-Lab raises fresh capital to build up its sales and marketing organization |
| 20 Jun 2008 | SIRS-Lab wins IQ innovation award |
| 26 May 2008 | SIRS-Lab publishes new study data |
| 21 Mar 2007 | SIRS Lab : expert service for gene expression |
| 14 Dec 2006 | Finanzierungsrunde von EUR 10M bei SIRS-Lab |
| 14 Dec 2006 | SIRS-Lab raises EUR 10M |
